Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.

5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • 5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases. Abstract Text:

    harold mastalerzHarold Mastalerz,ming changMing Chang,ping chenPing Chen,brian e finkBrian E Fink,ashvinikumar gavaiAshvinikumar Gavai,wen-ching hanWen-Ching Han,walter johnsonWalter Johnson,david langleyDavid Langley,francis y leeFrancis Y Lee,kenneth leavittKenneth Leavitt,punit marathePunit Marathe,derek norrisDerek Norris,simone oppenheimerSimone Oppenheimer,bogdan sleczkaBogdan Sleczka,james tarrantJames Tarrant,john s tokarskiJohn S Tokarski,gregory d viteGregory D Vite,dolatrai m vyasDolatrai M Vyas,henry wongHenry Wong,tai w wongTai W Wong,hongjian zhangHongjian Zhang,guifen zhangGuifen Zhang,

    Pyrrolotriazine dual EGFR/HER2 kinase inhibitors with a 5-((4-aminopiperidin-1-yl)methyl) solubilizing group were found to be superior to analogs with previously reported C-5 solubilizing groups. New synthetic methodology was developed for the parallel synthesis of C-4 analogs with the new solubilizing group. Interesting new leads were evaluated in tumor xenograft models and the C-4 aminofluorobenzylindazole, 1c, was found to exhibit the best antitumor activity. It is hypothesized that this solubilizing group extends into the ribose-phosphate portion of the ATP binding pocket and enhances the binding affinity of the inhibitor.

    5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases. Publishing Authors By Initials

    h mastalerzH Mastalerz,m changM Chang,p chenP Chen,be finkBE Fink,a gavaiA Gavai,wc hanWC Han,w johnsonW Johnson,d langleyD Langley,fy leeFY Lee,k leavittK Leavitt,p maratheP Marathe,d norrisD Norris,s oppenheimerS Oppenheimer,b sleczkaB Sleczka,j tarrantJ Tarrant,js tokarskiJS Tokarski,gd viteGD Vite,dm vyasDM Vyas,h wongH Wong,tw wongTW Wong,h zhangH Zhang,g zhangG Zhang,

    For similar heterocyclic compounds: heterocyclic compounds, 1-ring: triazines research abstracts see: heterocyclic compounds: heterocyclic compounds, 1-ring: triazines research

    PUBMED ID PMID:

    MEDLINE DATE:

    5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Bioorganic & medicinal chemistry letters

    VOLUME: 17

    Page Numbers: 4947-54

    Journal Abbreviation: Bioorg. Med. Chem. Lett.

    ISSN: 0960-894X

    DAY: 10

    MONTH: 06

    YEAR: 2007

    5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9107377

    5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases. Keywords Mesh Terms:

    KEYWORDS: Triazines

    MESH TERMS: pharmacology

    Chemical & Substance for Abstract: 5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases. Information

    Substance Name: Receptor, erbB-2

    Registry Number: EC 2.7.1.112

    Grant and Affiliation Information for 5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases.

    AFFILIATION: Department of Oncology Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, CT 06492-1951, USA. harold.mastalerz@bms.com

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Bioorg Med Chem Lett

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    5-4-Aminopiperidin-1-ylmethylpyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinases Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News